Navigating the Current Treatment Landscape in Esophageal Cancer with an Eye Toward the Future

Novartis sponsored ESMO 2021 Satellite Symposium: Navigating the Current Treatment Landscape

Faculty: Prof Eric Van Cutsem (Chair), Dr Elizabeth Smyth and Dr Lucjan Wyrwicz


  • Discuss the current patient journey and standards of care in esophageal cancer
  • Explore the current treatment landscape and latest data for the treatment of metastatic esophageal cancer in the first- and second-line setting
  • Discuss biomarkers and how they inform therapeutic decision-making in metastatic esophageal cancer
  • Identify the unmet needs of patients with esophageal cancer and how emerging immunotherapy regimens can potentially address these gaps